Healio spoke with experts about how the new administration could affect a range of important health issues, including vaccines, nutrition, chronic conditions, insurance and reproductive health ...

Treatment with IV edaravone for ALS was linked to a slowing of disease-progression milestones compared with no IV edaravone ...

The FDA has accepted Eisai and Biogen’s biologics license application for a monthly infusion of IV Leqembi to treat ...